- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Low-dose nivolumab in advanced hepatocellular carcinoma ; volume:22 ; number:1 ; day:8 ; month:11 ; year:2022 ; pages:1-12 ; date:12.2022
BMC cancer ; 22, Heft 1 (8.11.2022), 1-12, 12.2022
- Urheber
-
Chen, Yen-Hao
Wang, Chih-Chi
Chen, Yen-Yang
Wang, Jing-Houng
Hung, Chao-Hung
Kuo, Yuan-Hung
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-022-10271-6
- URN
-
urn:nbn:de:101:1-2023012209543418831886
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chen, Yen-Hao
- Wang, Chih-Chi
- Chen, Yen-Yang
- Wang, Jing-Houng
- Hung, Chao-Hung
- Kuo, Yuan-Hung
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer
ASO Author Reflections: Neoadjuvant Radiotherapy in Locally Advanced Esophageal Adenocarcinoma; Low-Dose Radiation, Low-Dose Expectations?
Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained Settings
Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports
Low-dose lithium against dementia
Low-dose oral methotrexate-induced crystalluria
Tumor Lysis Syndrome after Combination Therapy of Nivolumab and Sorafenib in a Woman with Advanced Hepatocellular Carcinoma
Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma
Low-dose quercetin positively regulates mouse healthspan
Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer
ASO Author Reflections: Neoadjuvant Radiotherapy in Locally Advanced Esophageal Adenocarcinoma; Low-Dose Radiation, Low-Dose Expectations?
Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained Settings
Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports
Low-dose lithium against dementia
Low-dose oral methotrexate-induced crystalluria
Tumor Lysis Syndrome after Combination Therapy of Nivolumab and Sorafenib in a Woman with Advanced Hepatocellular Carcinoma
Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma
Low-dose quercetin positively regulates mouse healthspan
Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer
ASO Author Reflections: Neoadjuvant Radiotherapy in Locally Advanced Esophageal Adenocarcinoma; Low-Dose Radiation, Low-Dose Expectations?
Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained Settings
Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports
Low-dose lithium against dementia
Low-dose oral methotrexate-induced crystalluria
Tumor Lysis Syndrome after Combination Therapy of Nivolumab and Sorafenib in a Woman with Advanced Hepatocellular Carcinoma
Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma